Literature DB >> 6979608

Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections.

C J Pfau, J K Valenti, D C Pevear, K D Hunt.   

Abstract

Two types of lymphocytic choriomeningitis (LCM) viruses were studied which, upon intracerebral injection into adult C3H mice, provoked either (a) acute fatal central nervous system (CNS) disease or (b) life-long persistent infection. Both virus types, (a) aggressive and (b) docile, had been found to induce LCM-specific lymphocytes with comparable in vitro lytic activity (11). Because the requirement for T cells in the development of adult LCM disease has been extensively documented, we sought other reasons for the lack of acute disease in mice infected with docile virus. A striking correlation was found between the outcome of the infection and spread of virus to visceral organs. Adoptive transfer experiments showed that a 300-plaque forming unit inoculum of docile virus induced a population of T cells in donor mice fully capable of causing CNS disease in identically infected recipients. This disease causing ability was lost if the interaction was delayed beyond 3 d after infection of the recipients, but could be preserved by lowering the size of the viral inoculum in the recipients. Furthermore, without adoptive transfer, very low intracerebral doses of docile virus (which mimicked the normally slow spread of aggressive virus) were lethal. On the other hand, very high doses of aggressive virus, which mimicked the normally rapid spread of docile virus, did not induce fatal CNS disease. The results suggest that rapid dissemination of the LCM infection creates multiple target organs which divert the focused lethal T cell attack on the brain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979608      PMCID: PMC2186718          DOI: 10.1084/jem.156.1.79

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS.

Authors:  M VOLKERT; J H LARSEN; C PFAU
Journal:  Acta Pathol Microbiol Scand       Date:  1964

2.  THE PATHOGENESIS OF LYMPHOCYTIC CHORIOMENINGITIS IN MICE: THE EFFECTS OF DIFFERENT INOCULATION ROUTES AND THE FOOTPAD RESPONSE.

Authors:  J HOTCHIN; L BENSON
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

3.  Lack of B-cell participation in acute lymphocyte choriomeningitis disease of the central nervous system.

Authors:  E D Johnson; A A Monjan; H C Morse
Journal:  Cell Immunol       Date:  1978-03-01       Impact factor: 4.868

Review 4.  The virology and immunobiology of lymphocytic choriomeningitis virus infection.

Authors:  M J Buchmeier; R M Welsh; F J Dutko; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

5.  Cytotoxic T cells are induced in mice infected with lymphocytic choriomeningitis virus strains of markedly different pathogenicities.

Authors:  C J Pfau; J K Valenti; S Jacobson; D C Pevear
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence.

Authors:  S Jacobson; R M Friedman; C J Pfau
Journal:  J Gen Virol       Date:  1981-12       Impact factor: 3.891

7.  Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.

Authors:  P C Doherty; R M Zinernagel
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

8.  H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.

Authors:  P C Doherty; R M Zinkernagel
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

9.  Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.

Authors:  D H Gilden; G A Cole; N Nathanson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  29 in total

1.  Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.

Authors:  Shenghua Zhou; Rong Ou; Lei Huang; Demetrius Moskophidis
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

Authors:  B Odermatt; M Eppler; T P Leist; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Genomic and biological characterization of aggressive and docile strains of lymphocytic choriomeningitis virus rescued from a plasmid-based reverse-genetics system.

Authors:  Minjie Chen; Shuiyun Lan; Rong Ou; Graeme E Price; Hong Jiang; Juan Carlos de la Torre; Demetrius Moskophidis
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

4.  A little 'help' from IL-21 during persistent viral infection.

Authors:  Dorian B McGavern
Journal:  J Mol Cell Biol       Date:  2009-10-01       Impact factor: 6.216

5.  Lymphocytic choriomeningitis virus-induced disease of the central nervous system and the "antigen-sink" hypothesis.

Authors:  D C Pevear; F Melio; C J Pfau
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

6.  Studies on immunity to lymphocytic choriomeningitis virus.

Authors:  R M Zinkernagel; T Leist; H Hengartner; B Pestalozzi; L Stitz
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

Review 7.  Biological role of major transplantation antigens in T cell self-recognition.

Authors:  R M Zinkernagel
Journal:  Experientia       Date:  1986-09-15

8.  Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon.

Authors:  D Moskophidis; M Battegay; M A Bruendler; E Laine; I Gresser; R M Zinkernagel
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology.

Authors:  M Battegay; S Oehen; M Schulz; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Consequences of a single Ir-gene defect for the pathogenesis of lymphocytic choriomeningitis.

Authors:  J E Allan; P C Doherty
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.